3X4 Genetics Revenue and Competitors
Estimated Revenue & Valuation
- 3X4 Genetics's estimated annual revenue is currently $6M per year.
- 3X4 Genetics's estimated revenue per employee is $155,000
Employee Data
- 3X4 Genetics has 39 Employees.
- 3X4 Genetics grew their employee count by 3% last year.
3X4 Genetics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CSO 3X4 Genetics | Reveal Email/Phone |
2 | Head Clinical Nutrition and Mentorship | Reveal Email/Phone |
3 | Head Enterprise Sales | Reveal Email/Phone |
4 | Head Marketing Operations, Community and Education | Reveal Email/Phone |
5 | Head Engineering | Reveal Email/Phone |
6 | Head Product | Reveal Email/Phone |
7 | General Manager & Head Business Development | Reveal Email/Phone |
8 | Product Owner | Reveal Email/Phone |
9 | CSO 3X4 Genetics | Reveal Email/Phone |
10 | Lead Nutrigenomics Mentor | Reveal Email/Phone |
3X4 Genetics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $35.4M | 222 | 52% | N/A | N/A |
What Is 3X4 Genetics?
Discover your personal genetics and tailor your diet + lifestyle to meet your body's unique needs. Better health, fitness, and overall wellbeing starts with a single cheek swab. 3x4 Genetics is a genetics-based health network that combines: advanced genetics testing, nutritional genomics education and a global network of accredited practitioners.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
3X4 Genetics News
2022-03-22 - Taking health tech to the world
A second technology, developed by 3X4 Genetics, also allows medical ... in bringing the power of genetic testing into medical practices,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.9M | 39 | 8% | N/A |
#2 | $6.9M | 39 | 39% | N/A |
#3 | $4.4M | 39 | N/A | N/A |
#4 | $8.1M | 40 | 29% | N/A |
#5 | $6.7M | 40 | -13% | N/A |